Search
for
Sort by
Research 151–180 of 1000+
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- ONCO-NK-TRANSITION-GM1: The Bridge Cancer Therapy Manufacturable by Current Pharmaceutical Industry — 60-80% Cure Rate — $50 per Dose A Complete Transitional Drug from Full N‑K GM Series to Current Pharma Capability
- Review of Drug Repositioning in Cancer Therapeutics
- A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
- Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment
- Application of Scaffold-Based Drug Delivery in Oral Cancer Treatment: A Novel Approach
- Transglutaminase 3: The Involvement in Epithelial Differentiation and Cancer
- A Transcriptome Sequencing Study on Genome-Wide Gene Expression Differences of Lung Cancer Cells Modulated by Fucoidan
- Molecular Mechanisms of Vitexin: An Update on Its Anti-Cancer Functions
- Diagnostic Value of VDR in Bone Metastasis and Prognosis of Patients with Breast Cancer and Expression Correlation between Vitamin D Receptor and Hairless Protein
- A Quantitative Measurement Method for Nuclear-Pleomorphism Scoring in Breast Cancer
- Inhaled Medicines for Targeting Non-Small Cell Lung Cancer
- Overcoming Curcumin's Limitations: Synthetic Derivatives in Diabetes and Cancer Management
- Biomedical Applications of Bee Venom: A Natural Approach to Cancer, Infections, and Inflammatory Diseases
- Understanding key symptoms, side effects, and impacts of HR+/HER2- advanced breast cancer: qualitative study findings
- Dissecting the genetic variations associated with response to first-line chemotherapy in patients with small cell lung cancer: a retrospective cohort study
- Referee report. For: Phytochemicals With Anti 5-alpha-reductase Activity: A Prospective For Prostate Cancer Treatment [version 3; peer review: 2 approved]
- Assessing the cost-effectiveness of DNA origami nanostructures for targeted delivery of anti-cancer drugs to tumours
- Ayurveda & Bioactives as Adjuvant for Dna Modulation in Cancer Treatment & Adverse Drug Reaction [ADR] – A Glimpse of Traditional Indian Nanotechnology
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Controversy: Synthetic hairs and their role in hair restoration?
- Diagnosis and Management of Melanoma of the Scalp: A Review of the Literature
- Cutaneous malignant melanoma incidences analyzed worldwide by skin type over advancing age of males and females: Evidence estrogen and androgenic hair are risk factors
- Recurrent facial microcystic adnexal carcinoma and hair transplantation on scar site
- How Biodegradable Polymers Can be Effective Drug Delivery Systems for Cannabinoids? Prospectives and Challenges
- WNT10A promotes an invasive and self-renewing phenotype in esophageal squamous cell carcinoma
- Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
- Novel Therapeutic Hybrid Systems Using Hydrogels and Nanotechnology: A Focus on Nanoemulgels for the Treatment of Skin Diseases
- Loss of ‘Epidermal Melanin Unit’ Integrity in Human Skin During Melanoma-Genesis
- Telocytes of the male reproductive system: dynamic tissue organizers